Literature DB >> 21858835

Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.

Alessandro Testori1, Cornelis Verhoef, Hidde M Kroon, E Pennacchioli, Mark B Faries, Alexander M M Eggermont, John F Thompson.   

Abstract

In-transit melanoma metastases are often confined to a limb. In this circumstance, treatment by isolated limb perfusion or isolated limb infusion can be a remarkably effective regional treatment option.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21858835     DOI： 10.1002/jso.22028

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  10 in total

Review 1.  Current treatment of locoregional recurrence of melanoma.

Authors:  Malcolm Hart Squires; Keith A Delman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

2.  Intratumoral talimogene laherparepvec therapy in melanoma.

Authors:  Kevin B Kim
Journal:  Melanoma Manag       Date:  2015-11-19

3.  Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma.

Authors:  Travis B Kidner; Donald L Morton; Delphine J Lee; Mary Hoban; Leland J Foshag; Roderick R Turner; Mark B Faries
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

4.  Isolated limb infusion in a series of over 100 infusions: a single-center experience.

Authors:  Joyce Wong; Y Ann Chen; Kate J Fisher; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2013-03-02       Impact factor: 5.344

5.  Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.

Authors:  Ravi P Sahu; Jesus A Ocana; Kathleen A Harrison; Matheus Ferracini; Christopher E Touloukian; Mohammed Al-Hassani; Louis Sun; Mathew Loesch; Robert C Murphy; Sandra K Althouse; Susan M Perkins; Paul J Speicher; Douglas S Tyler; Raymond L Konger; Jeffrey B Travers
Journal:  Cancer Res       Date:  2014-10-10       Impact factor: 12.701

6.  Hyperthermic intraperitoneal chemotherapy with melphalan: a summary of clinical and pharmacological data in 34 patients.

Authors:  Lana Bijelic; Paul H Sugarbaker; O Anthony Stuart
Journal:  Gastroenterol Res Pract       Date:  2012-07-03       Impact factor: 2.260

7.  Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit.

Authors:  Mitchell H Giles; Brendon J Coventry
Journal:  Cancer Manag Res       Date:  2013-08-20       Impact factor: 3.989

8.  Inclusion Complexes of Melphalan with Gemini-Conjugated β-Cyclodextrin: Physicochemical Properties and Chemotherapeutic Efficacy in In-Vitro Tumor Models.

Authors:  Waleed Mohammed-Saeid; Abdalla H Karoyo; Ronald E Verrall; Lee D Wilson; Ildiko Badea
Journal:  Pharmaceutics       Date:  2019-08-22       Impact factor: 6.321

9.  Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis.

Authors:  Junko Johansson; Roberta Kiffin; Ebru Aydin; Malin S Nilsson; Kristoffer Hellstrand; Per Lindnér; Peter Naredi; Roger Olofsson Bagge; Anna Martner
Journal:  Oncoimmunology       Date:  2019-11-03       Impact factor: 8.110

10.  Treatment of in-transit melanoma with intralesional bacillus Calmette-Guérin (BCG) and topical imiquimod 5% cream: a report of 3 cases.

Authors:  Nour Kibbi; Stephan Ariyan; Mark Faries; Jennifer N Choi
Journal:  J Immunother       Date:  2015 Nov-Dec       Impact factor: 4.456
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.